Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 29, 2020 - Issue 7
Submit an article Journal homepage
659
Views
11
CrossRef citations to date
0
Altmetric
Drug Evaluation

Teprotumumab: a novel therapeutic monoclonal antibody for thyroid-associated ophthalmopathy

Dane H. Slentza Department of Ophthalmology and Visual Sciences, W. K Kellogg Eye Center, University of Michigan Medical School, Ann Arbor, MIUSACorrespondence[email protected]
View further author information
,
Christine C. Nelsona Department of Ophthalmology and Visual Sciences, W. K Kellogg Eye Center, University of Michigan Medical School, Ann Arbor, MIUSAView further author information
&
Terry J. Smitha Department of Ophthalmology and Visual Sciences, W. K Kellogg Eye Center, University of Michigan Medical School, Ann Arbor, MIUSA;b Division of Metabolism, and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MIUSACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6279-9685View further author information
ORCID Icon
Pages 645-649 | Published online: 10 Jun 2020

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jan Wolf, Kamila I. Mitka, Alicja Hubalewska-Dydejczyk, Irene Krämer & George J Kahaly. (2022) Drug safety in thyroid eye disease – a systematic review. Expert Opinion on Drug Safety 21:7, pages 881-912.
Read now

Articles from other publishers (10)

Gillian R. Paton, Brady Kwong & Madhura A. Tamhankar. (2023) Successful Treatment of Bilateral Compressive Optic Neuropathy With Teprotumumab. Journal of Neuro-Ophthalmology 43:4, pages e209-e210.
Crossref
Michal Kršek. (2023) What's new in endocrinology?. Vnitřní lékařství 69:7, pages 469-472.
Crossref
Fan Cao, Zhuo-Ran Liu, Qin-Yu Ni, Chen-Kai Zha, Shu-Jie Zhang, Jia-Min Lu, Yue-Yang Xu, Li-Ming Tao, Zheng-Xuan Jiang & Hai-Feng Pan. (2023) Emerging roles of air pollution and meteorological factors in autoimmune eye diseases. Environmental Research 231, pages 116116.
Crossref
Joonyoung Baeg, Han Sol Choi, Charm Kim, Hyuna Kim & Sun Young Jang. (2023) Update on the surgical management of Graves’ orbitopathy. Frontiers in Endocrinology 13.
Crossref
Syuan-Ling Lin, Chih-Yang Lin, Wei Lee, Chiao-Fang Teng, Woei-Cherng Shyu & Long-Bin Jeng. (2022) Mini Review: Molecular Interpretation of the IGF/IGF-1R Axis in Cancer Treatment and Stem Cells-Based Therapy in Regenerative Medicine. International Journal of Molecular Sciences 23:19, pages 11781.
Crossref
A. Yan Lun, M. Le Bras, E. Scharbarg, P. Morcel, S. Hadjadj, P. Lebranchu & D. Drui. (2022) L’orbitopathie basedowienne: diagnostic, épidémiologie et principes de traitement. La Revue de Médecine Interne 43:4, pages 242-251.
Crossref
Jianshu Kang, Yunqin Li, Yue Zou, Zhijian Zhao, Linan Jiao & Hong Zhang. (2022) miR-96-5p Induces Orbital Fibroblasts Differentiation by Targeting Smad7 and Promotes the Development of Thyroid-Associated Ophthalmopathy. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-11.
Crossref
Julia Kang, Maria Lechuga, Jenna Braun, Andrea Kossler, Raymond Douglas & Kimberly Cockerham. (2021) Infusion Center Guidelines for Teprotumumab Infusions: Informed Consent, Safety, and Management of Side Effects. Journal of Infusion Nursing 44:6, pages 331-338.
Crossref
Sung Eun Kim, Jia Kim, Ji-Young Lee, Seong-Beom Lee, Ji-Sun Paik & Suk-Woo Yang. (2021) Octreotide inhibits secretion of IGF-1 from orbital fibroblasts in patients with thyroid-associated ophthalmopathy via inhibition of the NF-κB pathway. PLOS ONE 16:4, pages e0249988.
Crossref
Susanne Neumann, Christine C. Krieger & Marvin C. Gershengorn. (2020) Targeting TSH and IGF-1 Receptors to Treat Thyroid Eye Disease. European Thyroid Journal 9:Suppl. 1, pages 59-65.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.